title: Prospects for Moxidectin as a New Oral Treatment for Human Scabies.
authors.affiliation: Inflammation & Healing Research Cluster, School of Health and Sport Sciences, University of the Sunshine Coast, Maroochydore, Queensland, Australia.|Infectious Diseases & Immunology Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
authors.forename: Kate E
authors.initials: KE
authors.lastname: Mounsey
authors.affiliation: Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Bernigaud
authors.affiliation: Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.|Université Paris-est Créteil Val de Marne, Créteil, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Chosidow
authors.affiliation: Infectious Diseases & Immunology Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.|School of Medicine, University of Queensland, Herston, Queensland, Australia.
authors.forename: James S
authors.initials: JS
authors.lastname: McCarthy
mesh_terms: D056810:Acaricides / Q000627:therapeutic use*; D000284:Administration, Oral; D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D058492:Drug Repositioning; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D012532:Scabies / Q000188:drug therapy*
chemical_list: D056810:Acaricides; D018942:Macrolides; C027837:moxidectin